Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.

J Allergy Clin Immunol Pract

University of Washington Medical Center, Seattle, Wash; Center for Allergy and Inflammation, UW Medicine at South Lake Union, Seattle, Wash.

Published: June 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2017.01.013DOI Listing

Publication Analysis

Top Keywords

combination omalizumab
4
omalizumab mepolizumab
4
mepolizumab therapy
4
therapy refractory
4
refractory allergic
4
allergic bronchopulmonary
4
bronchopulmonary aspergillosis
4
combination
1
mepolizumab
1
therapy
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!